Cardiac regeneration: Options for repairing the injured heart

Cardiac regeneration is one of the grand challenges in repairing injured human hearts. Numerous studies of signaling pathways and metabolism on cardiac development and disease pave the way for endogenous cardiomyocyte regeneration. New drug delivery approaches, high-throughput screening, as well as novel therapeutic compounds combined with gene editing will facilitate the development of potential cell-free therapeutics. In parallel, progress has been made in the field of cell-based therapies. Transplantation of human pluripotent stem cell (hPSC)-derived cardiomyocytes (hPSC-CMs) can partially rescue the myocardial defects caused by cardiomyocyte loss in large animals. In this review, we summarize current cell-based and cell-free regenerative therapies, discuss the importance of cardiomyocyte maturation in cardiac regenerative medicine, and envision new ways of regeneration for the injured heart.

[1]  K. Chien,et al.  Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  F. Lescroart,et al.  Single Cell Approaches to Understand the Earliest Steps in Heart Development , 2022, Current Cardiology Reports.

[3]  G. Vunjak‐Novakovic,et al.  Progress in multicellular human cardiac organoids for clinical applications. , 2022, Cell stem cell.

[4]  M. Link,et al.  2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2022, Circulation.

[5]  C. Simmons,et al.  In Vitro Matured Human Pluripotent Stem Cell–Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts , 2022, Circulation.

[6]  T. Watabe,et al.  Transplantation of IPSC-Derived Cardiomyocyte Patches for Ischemic Cardiomyopathy , 2022, medRxiv.

[7]  Dilip Thomas,et al.  Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production , 2022 .

[8]  James F. Martin,et al.  Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming , 2021, Journal of the American Heart Association.

[9]  X. Chen,et al.  Adrenergic-Thyroid Hormone Interactions Drive Postnatal Thermogenesis and Loss of Mammalian Heart Regenerative Capacity. , 2021, Circulation.

[10]  G. Gerosa,et al.  Marginal donors and organ shortness: concomitant surgical procedures during heart transplantation: a literature review , 2021, Journal of cardiovascular medicine.

[11]  J. Qian,et al.  Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration. , 2021, Biomaterials.

[12]  M. Wheeler,et al.  Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations , 2021, Stem cell research.

[13]  L. Lanier,et al.  Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice , 2021, Proceedings of the National Academy of Sciences.

[14]  Dan C. Wilkinson,et al.  Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells , 2021, Nature Communications.

[15]  E. Morii,et al.  Evaluation of the Efficacy and Safety of a Clinical Grade Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch: A Pre-Clinical Study , 2021, bioRxiv.

[16]  Dilip Thomas,et al.  Human iPSCs in Cardiovascular Research: Current Approaches in Cardiac Differentiation, Maturation Strategies, and Scalable Production. , 2021, Cardiovascular research.

[17]  Y. Tabata,et al.  Intramyocardial Transplantation of Human iPS Cell–Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals , 2021, JACC. Basic to translational science.

[18]  Lauren E. Neidig,et al.  Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes , 2021, bioRxiv.

[19]  T. Šarić,et al.  Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stages , 2021, Stem cell research & therapy.

[20]  M. Novatchkova,et al.  Cardioids reveal self-organizing principles of human cardiogenesis , 2020, Cell.

[21]  E. Olson,et al.  Cell-Type-Specific Gene Regulatory Networks Underlying Murine Neonatal Heart Regeneration at Single-Cell Resolution , 2020, Cell reports.

[22]  N. Gray,et al.  Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development , 2020, Cell.

[23]  Li Li,et al.  LRP6 downregulation promotes cardiomyocyte proliferation and heart regeneration , 2020, Cell Research.

[24]  G. Keller,et al.  Transplanted microvessels improve pluripotent stem cell–derived cardiomyocyte engraftment and cardiac function after infarction in rats , 2020, Science Translational Medicine.

[25]  H. Ly,et al.  Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes , 2020, Journal of translational medicine.

[26]  Wesley L. McKeithan,et al.  Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes , 2020, Cell reports.

[27]  Ziyi Yang,et al.  Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes , 2020, Stem Cell Research & Therapy.

[28]  Wuqiang Zhu,et al.  Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease , 2020, Frontiers in Bioengineering and Biotechnology.

[29]  S. Mallapaty.  Revealed: two men in China were first to receive pioneering stem-cell treatment for heart disease , 2020, Nature.

[30]  Michael C. McAlpine,et al.  In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid , 2020, Circulation research.

[31]  Jiaxian Wang,et al.  Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts , 2020, Stem Cell Research & Therapy.

[32]  O. Bergmann,et al.  Polyploidy in Cardiomyocytes , 2020, Circulation research.

[33]  M. Mayr,et al.  Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration , 2020, Circulation.

[34]  Zhenwei Pan,et al.  Targeting LncDACH1 promotes cardiac repair and regeneration after myocardium infarction , 2020, Cell Death & Differentiation.

[35]  J. Molkentin,et al.  An acute immune response underlies the benefit of cardiac stem cell therapy , 2019, Nature.

[36]  E. Olson,et al.  Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling , 2019, Proceedings of the National Academy of Sciences.

[37]  Xiuzhen Huang,et al.  Reassessment of c-Kit+ Cells for Cardiomyocyte Contribution in Adult Heart. , 2019, Circulation.

[38]  G. Hasenfuss,et al.  Proteasome-Dependent Regulation of Distinct Metabolic States During Long-Term Culture of Human iPSC-Derived Cardiomyocytes. , 2019, Circulation research.

[39]  G. Wright,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias , 2019, Stem cell reports.

[40]  Lu Wen,et al.  Single-Cell Transcriptome Analysis Maps the Developmental Track of the Human Heart. , 2019, Cell reports.

[41]  Guangju Ji,et al.  A chemical approach for global protein knockdown from mice to non-human primates , 2019, Cell Discovery.

[42]  H. Baharvand,et al.  Human cardiomyocytes undergo enhanced maturation in embryonic stem cell-derived organoid transplants. , 2019, Biomaterials.

[43]  T. Watabe,et al.  Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction , 2019, Transplantation.

[44]  Fengtang Yang,et al.  Human blood vessel organoids as a model of diabetic vasculopathy , 2019, Nature.

[45]  G. Tomaselli,et al.  Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment. , 2019, Journal of molecular and cellular cardiology.

[46]  Kathy O. Lui,et al.  Fate Mapping of Sca1+ Cardiac Progenitor Cells in the Adult Mouse Heart. , 2018, Circulation.

[47]  Jianyun Yan,et al.  Cardiac Sca-1+ Cells Are Not Intrinsic Stem Cells for Myocardial Development, Renewal, and Repair , 2018, Circulation.

[48]  E. Srour,et al.  Absence of Cardiomyocyte Differentiation Following Transplantation of Adult Cardiac-Resident Sca-1+ Cells Into Infarcted Mouse Hearts. , 2018, Circulation.

[49]  J. Molkentin,et al.  Genetic Lineage Tracing of Sca-1+ Cells Reveals Endothelial but Not Myogenic Contribution to the Murine Heart , 2018, Circulation.

[50]  Lauren E. Neidig,et al.  Evidence for Minimal Cardiogenic Potential of Stem Cell Antigen 1–Positive Cells in the Adult Mouse Heart , 2018, Circulation.

[51]  Jianyi(Jay) Zhang,et al.  Regenerative Potential of Neonatal Porcine Hearts , 2018, Circulation.

[52]  Zhen Gu,et al.  Cardiac cell–integrated microneedle patch for treating myocardial infarction , 2018, Science Advances.

[53]  N. Weintraub,et al.  Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium , 2018, Journal of Cardiovascular Translational Research.

[54]  R. Michler.  The current status of stem cell therapy in ischemic heart disease , 2018, Journal of cardiac surgery.

[55]  Lil Pabon,et al.  Human ESC-Derived Cardiomyocytes Restore Function in Infarcted Hearts of Non-Human Primates , 2018, Nature Biotechnology.

[56]  Gordana Vunjak-Novakovic,et al.  Advanced maturation of human cardiac tissue grown from pluripotent stem cells , 2018, Nature.

[57]  Kathy O. Lui,et al.  Endocardial Cell Plasticity in Cardiac Development, Diseases and Regeneration. , 2018, Circulation research.

[58]  Joe Z. Zhang,et al.  Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction , 2018, Stem cell reports.

[59]  M. Stojkovic,et al.  Ethical and Safety Issues of Stem Cell-Based Therapy , 2018, International journal of medical sciences.

[60]  D. Srivastava,et al.  Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration , 2017, Cell.

[61]  Matthew C. Hill,et al.  Hippo Pathway Deficiency Reverses Systolic Heart Failure Post-Infarction , 2017, Nature.

[62]  Takashi Daimon,et al.  Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model , 2017, Scientific Reports.

[63]  N. Bursac,et al.  The extracellular matrix protein agrin promotes heart regeneration in mice , 2017, Nature.

[64]  W. Strohl,et al.  Adeno-Associated Virus (AAV) as a Vector for Gene Therapy , 2017, BioDrugs.

[65]  Nadeera M. Wickramasinghe,et al.  Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair , 2017, Cell Research.

[66]  Yang Xiao,et al.  Dystrophin Glycoprotein Complex Sequesters Yap to Inhibit Cardiomyocyte Proliferation , 2017, Nature.

[67]  T. Okano,et al.  Local Release of VEGF Using Fiber Mats Enables Effective Transplantation of Layered Cardiomyocyte Sheets. , 2017, Macromolecular bioscience.

[68]  A. Haverich,et al.  Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction , 2017, PloS one.

[69]  D. Srivastava,et al.  Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming , 2017, Circulation.

[70]  Diana C. Canseco,et al.  Hypoxia induces heart regeneration in adult mice , 2016, Nature.

[71]  Lil Pabon,et al.  In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts , 2017, Stem cell reports.

[72]  Deok‐Ho Kim,et al.  Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening. , 2017, Biotechnology advances.

[73]  M. Ohkura,et al.  Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts , 2016, Nature.

[74]  Lil Pabon,et al.  Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue , 2016, Circulation.

[75]  J. Penninger,et al.  A reproducible protocol for neonatal ischemic injury and cardiac regeneration in neonatal mice , 2016, Basic Research in Cardiology.

[76]  Yu Zhang,et al.  Conversion of human fibroblasts into functional cardiomyocytes by small molecules , 2016, Science.

[77]  Kathy O. Lui,et al.  GATA4 regulates Fgf16 to promote heart repair after injury , 2016, Development.

[78]  J. Penninger,et al.  Functional Recovery of a Human Neonatal Heart After Severe Myocardial Infarction. , 2016, Circulation research.

[79]  Alexander van Oudenaarden,et al.  Spatially Resolved Genome-wide Transcriptional Profiling Identifies BMP Signaling as Essential Regulator of Zebrafish Cardiomyocyte Regeneration. , 2016, Developmental cell.

[80]  S. Yamanaka,et al.  Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes , 2016, Scientific Reports.

[81]  A. Moon,et al.  Resident c-kit+ cells in the heart are not cardiac stem cells , 2015, Nature Communications.

[82]  X. Kong,et al.  GW26-e3523 miR-31a-5p controls cardiomyocyte proliferation in postnatal hearts , 2015 .

[83]  Bin Zhou,et al.  Epicardial FSTL1 reconstitution regenerates the adult mammalian heart , 2015, Nature.

[84]  Xinli Li,et al.  Abstract 309: MiR-31a-5p Controls Cardiomyocyte Proliferation in Postnatal Hearts , 2015 .

[85]  I. Karakikes,et al.  Induced Pluripotent Stem Cell–Derived Cardiomyocytes: A New and Versatile Human In Vitro Cardiomyocyte Model Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Insights Into Molecular, Cellular, and Functional Phenotypes , 2015 .

[86]  Kaytlyn A. Gerbin,et al.  The winding road to regenerating the human heart. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[87]  M. Neeman,et al.  ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation , 2015, Nature Cell Biology.

[88]  A. Schally,et al.  Growth Hormone–Releasing Hormone Agonists Reduce Myocardial Infarct Scar in Swine With Subacute Ischemic Cardiomyopathy , 2015, Journal of the American Heart Association.

[89]  Tao Wang,et al.  A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice , 2015, Science Translational Medicine.

[90]  F. van Roy,et al.  Alpha-Catenins Control Cardiomyocyte Proliferation by Regulating Yap Activity , 2015, Circulation research.

[91]  M. Giacca,et al.  In vivo activation of a conserved microRNA program induces mammalian heart regeneration. , 2014, Cell stem cell.

[92]  Roger A. Pedersen,et al.  NANOG and CDX2 pattern distinct subtypes of human mesoderm during exit from pluripotency. , 2014, Cell stem cell.

[93]  K. Red-Horse,et al.  Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3–Induced Myocarditis and Antiviral Drug Screening Platform , 2014, Circulation research.

[94]  Praveen Shukla,et al.  Chemically defined generation of human cardiomyocytes , 2014, Nature Methods.

[95]  David T. Paik,et al.  Endothelial cells contribute to generation of adult ventricular myocytes during cardiac homeostasis. , 2014, Cell reports.

[96]  H. Ruohola-Baker,et al.  Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. , 2014, Journal of molecular and cellular cardiology.

[97]  Paul W. Burridge,et al.  Human Stem Cells for Modeling Heart Disease and for Drug Discovery , 2014, Science Translational Medicine.

[98]  E. Marbán,et al.  c-kit+ Cells Minimally Contribute Cardiomyocytes to the Heart , 2014, Nature.

[99]  Charles E. Murry,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.

[100]  E. Olson,et al.  Surgical models for cardiac regeneration in neonatal mice , 2014, Nature Protocols.

[101]  Pieter A. Doevendans,et al.  Sustained Delivery of Insulin-Like Growth Factor-1/Hepatocyte Growth Factor Stimulates Endogenous Cardiac Repair in the Chronic Infarcted Pig Heart , 2014, Journal of Cardiovascular Translational Research.

[102]  Arunima Sengupta,et al.  Tbx20 promotes cardiomyocyte proliferation and persistence of fetal characteristics in adult mouse hearts. , 2013, Journal of molecular and cellular cardiology.

[103]  Wei-Zhong Zhu,et al.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. , 2013, Stem cells and development.

[104]  Richard T. Lee,et al.  An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential , 2013, Circulation.

[105]  Fatih Kocabaş,et al.  Meis1 regulates postnatal cardiomyocyte cell cycle arrest , 2013, Nature.

[106]  U. Lendahl,et al.  Regenerative medicine for the treatment of heart disease , 2013, Journal of internal medicine.

[107]  Euan A Ashley,et al.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.

[108]  Sean P. Palecek,et al.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.

[109]  L. Zentilin,et al.  Functional screening identifies miRNAs inducing cardiac regeneration , 2012, Nature.

[110]  T. Aitman,et al.  Complete cardiac regeneration in a mouse model of myocardial infarction , 2012, Aging.

[111]  Takashi Daimon,et al.  Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.

[112]  Atsushi Izawa,et al.  hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts , 2012, Nature.

[113]  Teruo Okano,et al.  Pluripotent Stem Cell‐Engineered Cell Sheets Reassembled with Defined Cardiovascular Populations Ameliorate Reduction in Infarct Heart Function Through Cardiomyocyte‐Mediated Neovascularization , 2012, Stem cells.

[114]  Leah B. Honor,et al.  YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy , 2012, Proceedings of the National Academy of Sciences.

[115]  Li Qian,et al.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.

[116]  Gang Wang,et al.  Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy , 2011, Nature Cell Biology.

[117]  E. Olson,et al.  Transient Regenerative Potential of the Neonatal Mouse Heart , 2011, Science.

[118]  M. Gnecchi,et al.  Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. , 2011, Journal of molecular and cellular cardiology.

[119]  J. Gold,et al.  Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. , 2010, Journal of molecular and cellular cardiology.

[120]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[121]  David M. Harris,et al.  Glycogen Synthase Kinase-3&bgr; Regulates Post–Myocardial Infarction Remodeling and Stress-Induced Cardiomyocyte Proliferation In Vivo , 2010, Circulation research.

[122]  J. C. Belmonte,et al.  Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation , 2010, Nature.

[123]  Kevin Bersell,et al.  Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury , 2009, Cell.

[124]  Mitsuru Nenoi,et al.  Regulation of , 2004 .

[125]  L. Zentilin,et al.  Notch1 signaling stimulates proliferation of immature cardiomyocytes , 2008, The Journal of cell biology.

[126]  C. Murry,et al.  Systems approaches to preventing transplanted cell death in cardiac repair. , 2008, Journal of molecular and cellular cardiology.

[127]  Lars S. Maier,et al.  Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem Cells , 2008, Circulation.

[128]  S. Kong,et al.  GATA4 Is a Direct Transcriptional Activator of Cyclin D2 and Cdk4 and Is Required for Cardiomyocyte Proliferation in Anterior Heart Field-Derived Myocardium , 2008, Molecular and Cellular Biology.

[129]  Gordon Keller,et al.  Differentiation of Embryonic Stem Cells to Clinically Relevant Populations: Lessons from Embryonic Development , 2008, Cell.

[130]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[131]  T. Borchardt,et al.  Re-programming of newt cardiomyocytes is induced by tissue regeneration , 2006, Journal of Cell Science.

[132]  Richard T. Lee,et al.  FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction , 2006, Proceedings of the National Academy of Sciences.

[133]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[134]  Richard K. Cheng,et al.  Therapeutic Delivery of Cyclin A2 Induces Myocardial Regeneration and Enhances Cardiac Function in Ischemic Heart Failure , 2006, Circulation.

[135]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[136]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[137]  I. Komuro,et al.  Adult Cardiac Sca-1-positive Cells Differentiate into Beating Cardiomyocytes* , 2004, Journal of Biological Chemistry.

[138]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[139]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[140]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[141]  M. Entman,et al.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.

[142]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.